Qilian International Holding Group (Qilian International Holding Group) Long-Term Capital Lease Obligation : $0.03 Mil (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Qilian International Holding Group Long-Term Capital Lease Obligation?

Qilian International Holding Group's Long-Term Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.03 Mil.

Qilian International Holding Group's quarterly Long-Term Capital Lease Obligation declined from Sep. 2022 ($0.07 Mil) to Mar. 2023 ($0.05 Mil) and declined from Mar. 2023 ($0.05 Mil) to Sep. 2023 ($0.03 Mil).

Qilian International Holding Group's annual Long-Term Capital Lease Obligation declined from Sep. 2021 ($0.11 Mil) to Sep. 2022 ($0.07 Mil) and declined from Sep. 2022 ($0.07 Mil) to Sep. 2023 ($0.03 Mil).

Qilian International Holding Group Long-Term Capital Lease Obligation Historical Data

The historical data trend for Qilian International Holding Group's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qilian International Holding Group Long-Term Capital Lease Obligation Chart

Qilian International Holding Group Annual Data

Trend

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.16

0.11

0.07

0.03

Qilian International Holding Group Semi-Annual Data
	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial								0.11	0.08	0.07	0.05	0.03

Qilian International Holding Group (NAS:QLI) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Qilian International Holding Group Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Qilian International Holding Group's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Qilian International Holding Group (Qilian International Holding Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qilian International Holding Group Ltd (NAS:QLI) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jiuquan Economic and Technological Development Zone, Gansu Province, Jiuquan, CHN, 735000

Website

http://ir.qlsyy.net

Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generates majority of the revenue.